Sign in
4

Changes in Ownership

Nuvectis Pharma, Inc. Filed Acc 0001104659-22-062271

Chief Dev. & Ops. Officer bought 242 shares at an average $19.44 ($4,704)

From the SEC's structured data for this filing

Trades in this filing

Shemesh Shay · Chief Dev. & Ops. Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-05-16 Purchase : show line 1 in the form +100 $19.28 $1,928 1,240,993 D
2022-05-17 Purchase : show line 2 in the form +142 $19.55 $2,776 1,241,135 D
Open-market purchases · 242 sh · avg $19.44 · $4,704
Loading xslF345X03/tm2215754-2_4seq1.xml…